SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dhanvantri Jeevan Rekha Ltd (531043)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531043 NSE: Hospital & Healthcare Services | Small Cap | DhanvantriJeevan Rek Share Price

₹27.41 -1.44 (-4.99%)

As on 02-Jul'26 16:59

Dhanvantri Jeevan Rekha Ltd (531043)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531043 NSE: Hospital & Healthcare Services | Small Cap | DhanvantriJeevan Rek Share Price

₹27.41 -1.44 (-4.99%)

As on 02-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹11 Cr.
Current Price
₹27.4
52-Week Low / High
₹19 / 36
TTM EPS
₹1
TTM Sales
₹25.9 Cr.
Book Value per Share
₹25.5
P/E Ratio
28.08
Higher than its 5-year historical median
Industry PE
93.2
Price to Book (P/B)
1.07
Higher than its 5-year historical median
Price to Sales (P/S)
0.43
Higher than its 5-year historical median
EV/EBITDA
7.00
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
5.19%
Underperforms industry median
Return on Capital Employed (ROCE)
5.80%
Underperforms industry median
Return on Assets (ROA)
3.40%
Operating Profit Margin
3.2%
Net Profit Margin
2.23%
Gross Profit Margin
5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
10.7%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
-13.25%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
200%
Asset Quality
Promoter Holding
19.65%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹6 Cr.
Equity
₹4.1 Cr.
Face Value
₹10
All Time Low / High
₹3.69 / 61.70

Dhanvantri Jeevan Rekha stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Dhanvantri Jeevan Rekha Ltd a good quality company?
Dhanvantri Jeevan Rekha Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Dhanvantri Jeevan Rekha Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Dhanvantri Jeevan Rekha Ltd vs industry peers?
Dhanvantri Jeevan Rekha Ltd revenue CAGR is 4.46%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Dhanvantri Jeevan Rekha Ltd?
Promoters hold 19.65% of the Dhanvantri Jeevan Rekha Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Dhanvantri Jeevan Rekha Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -5.2% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dhanvantri Jeevan Rekha Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 16.7%11.8%7.9%2%-2.6%-16.4%7.4%-1.5%2.8%5.8%-
Value Creation
Index
0.2-0.2-0.4-0.9-1.2-2.2-0.5-1.1-0.8-0.6-

Growth Parameters

Sales 9.311.213.716.818.29.816.817.720.522.726
Sales YoY Gr.-20.6%23%22.5%8.2%-46.3%71.4%5.5%15.7%10.7%-
Adj EPS 2.32.11.80.1-0.6-3.51.2-0.50.41.21
YoY Gr.--10.7%-14.4%-93.8%-681.8%NANA-144.2%NA210%-
BVPS (₹) 22.824.125.92625.421.923.122.62324.625.5
Adj Net
Profit
10.90.70.1-0.3-1.40.5-0.20.20.50
Cash Flow from Ops. 1.33.50.91.31.4-0.41.1-0.43-0.3-
Debt/CF from Ops. 002.20.10.1-0.20000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 10.5%4.5%10.6%10.7%
Adj EPS -6.8%NA1.1%210%
BVPS0.8%-0.6%2.1%7%
Share Price 0.1% 30.4% 32.1% 26.8%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
10.78.87.10.4-2.5-14.65.3-2.31.85.23.9
Op. Profit
Mgn %
15.614.413.57.33.7-7.78.93.34.13.22.9
Net Profit
Mgn %
10.37.65.30.3-1.5-14.62.9-1.20.82.21.6
Debt to
Equity
000.200000000
Working Cap
Days
1741228271631077283705837
Cash Conv.
Cycle
241212201732223128174

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales9.2611.1713.7416.8318.219.7816.7617.6820.4622.65
Operating Expenses + 7.811011.8915.6017.5410.5315.2717.1019.6321.93
Manufacturing Costs5.386.988.4010.6813.026.8310.1211.5314.1415.69
Material Costs000000.02-0.03-0.020.02-0.03
Employee Cost 2.032.162.753.733.582.363.223.784.264.80
Other Costs 0.410.870.741.190.941.321.971.821.211.47
Operating Profit 1.451.161.851.230.66-0.751.490.580.830.72
Operating Profit Margin (%) 15.6%10.4%13.5%7.3%3.7%-7.7%8.9%3.3%4.1%3.2%
Other Income + 0.310.350.140.120.160.180.210.240.290.41
Exceptional Items 0000000000
Interest 0.080.180.220.110.040.020.020.010.010.01
Depreciation 0.270.371.101.131.101.041.020.960.870.56
Profit Before Tax 1.410.970.670.12-0.32-1.630.67-0.140.260.56
Tax 0.460.42-0.060.07-0.05-0.210.180.070.090.05
Profit After Tax 0.950.550.730.05-0.26-1.420.49-0.220.170.51
PAT Margin (%) 10.3%4.9%5.3%0.3%-1.5%-14.6%2.9%-1.2%0.8%2.2%
Adjusted EPS (₹)2.31.31.80.1-0.6-3.51.2-0.50.41.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of DhanvantriJeevan Rek - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 9.409.9510.6810.7210.469.049.539.319.4710.13
Share Capital 4.154.154.154.154.154.154.154.154.154.15
Reserves 5.255.796.526.576.304.885.375.155.325.98
Debt +001.950.100.100.070000
Long Term Debt001.950.100.100.070000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables000.010000.840.430.800.83
Others Liabilities 3.296.313.754.444.154.563.884.084.753.79
Total Liabilities 12.6916.2616.3815.2714.7013.6714.2413.8115.0214.75

Fixed Assets

Net Fixed Assets +5.1712.0712.2811.4410.689.728.858.548.148.41
Gross Block12.9820.6921.5621.8522.1922.2722.4223.0623.5324.30
Accumulated Depreciation7.818.629.2810.4111.5112.5513.5714.5215.3915.89
CWIP 2.62000.12000000
Investments 0000000000
Inventories0.010.010.050.110.110.090.120.140.130.15
Trade Receivables0.520.190.671.030.451.071.712.451.751.80
Cash Equivalents 0.6111.120.111.310.911.800.853.502.55
Others Assets 3.752.982.272.452.151.891.761.831.511.84
Total Assets 12.6916.2616.3815.2714.7013.6714.2413.8115.0214.75

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 1.323.520.891.271.38-0.351.05-0.393.03-0.29
PBT 0.950.550.730.12-0.32-1.480.67-0.150.220.62
Adjustment 0.551.211.161.141.070.990.940.870.790.39
Changes in Working Capital -0.181.77-10.010.630.14-0.57-1.122.02-1.3
Tax Paid 0000000000
Cash Flow From Investing Activity + -1.33-3.99-0.57-0.31-0.14-0-0.06-0.56-0.39-0.66
Capex -1.58-5.08-1.31-0.41-0.22-0.08-0.15-0.64-0.46-0.84
Net Investments -00.900.640000000
Others 0.250.190.100.100.080.080.090.080.070.18
Cash Flow From Financing Activity + 0.310.87-0.21-1.96-0.04-0.05-0.09000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000.010000000
Interest Paid -0.07-0.17-0.22-0.11-0.04-0.02-0.02000
Dividend Paid 0000000000
Others 0.381.04-0-1.85-0-0.03-0.07000
Net Cash Flow 0.300.400.11-11.19-0.400.90-0.952.64-0.95

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)10.755.687.10.44-2.51-14.695.31-2.311.775.19
ROCE (%)16.7111.797.911.97-2.55-16.377.4-1.462.785.8
Asset Turnover Ratio0.770.770.841.061.220.691.21.261.421.52
PAT to CFO Conversion(x)1.396.41.2225.4N/AN/A2.14N/A17.82-0.57
Working Capital Days
Receivable Days23.4011.6011.4018.5014.9028.4030.304337.5028.60
Inventory Days0.500.500.901.702.203.702.202.702.402.20
Payable Days0000000-9,882.2000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dhanvantri Jeevan Rekha Ltd FAQs

The current trading price of DhanvantriJeevan Rek on 02-Jul-2026 16:59 is ₹27.41.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of DhanvantriJeevan Rek stood at ₹11.23 Cr

The latest P/E ratio of DhanvantriJeevan Rek as of 01-Jul-2026 is 28.08.

The latest P/B ratio of DhanvantriJeevan Rek as of 01-Jul-2026 is 1.07.

The 52-week high of DhanvantriJeevan Rek is ₹35.86 and the 52-week low is ₹19.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of DhanvantriJeevan Rek is ₹25.86 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dhanvantri Jeevan Rekha Ltd is a below average quality company.

The key valuation ratios of Dhanvantri Jeevan Rekha Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dhanvantri Jeevan Rekha Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Dhanvantri Jeevan Rekha Ltd

Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

It offers diagnostic and therapeutic facilities in all specialities, well equipped multidisciplinary intensive care units and cashless hospitalization for accredited patients.

The company is basically engaged in offering different medical facilities like Cardiac Care, Endourology, Gastroenterology, Neuro Surgery, Neurology, Anestheslogy and Orthopedic Surgery.

The company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging  (MRI). The company obtained certificate for commencement of business on August 2, 1993. The company was incorporated  with an authorized capital of Rs. 200 Lacs which was subsequently increased to Rs. 500 Lacs from time to time.

In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagnostic equipments in the Urology and Cardiology Sections have already been installed and are in operation. The company has acquired the adjacent plot in 2004 on which the future expansion plan is expected to commence shortly.

Services offered by the company:

  • Female Urology
  • Impotency
  • Infertility
  • Lithotripsy
  • Paediatric Urology
  • Cystometrogram
  • Uroflowmetry
  • Uro Oncology 
  • Uro Lithiasis
  • Stricture Urethra
  • Renal Transplant & Dialysis

Future plans :

  • A 100 bedded new wing
  • 30 bedded ICU.
  • Multislice spiral CT scan. 
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: